nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP3A7—Ifosfamide—germ cell cancer	0.122	0.191	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.122	0.191	CbGbCtD
Temsirolimus—CYP3A5—Ifosfamide—germ cell cancer	0.0914	0.143	CbGbCtD
Temsirolimus—ABCB1—Dactinomycin—germ cell cancer	0.0504	0.0789	CbGbCtD
Temsirolimus—CYP3A5—Etoposide—germ cell cancer	0.0437	0.0684	CbGbCtD
Temsirolimus—CYP3A4—Ifosfamide—germ cell cancer	0.0356	0.0558	CbGbCtD
Temsirolimus—ABCB1—Vinblastine—germ cell cancer	0.0315	0.0494	CbGbCtD
Temsirolimus—CYP2D6—Vinblastine—germ cell cancer	0.0297	0.0466	CbGbCtD
Temsirolimus—ABCB1—Cisplatin—germ cell cancer	0.0289	0.0453	CbGbCtD
Temsirolimus—ABCB1—Etoposide—germ cell cancer	0.0284	0.0445	CbGbCtD
Temsirolimus—CYP3A4—Vinblastine—germ cell cancer	0.0189	0.0296	CbGbCtD
Temsirolimus—ABCB1—Methotrexate—germ cell cancer	0.0188	0.0294	CbGbCtD
Temsirolimus—CYP3A4—Etoposide—germ cell cancer	0.017	0.0267	CbGbCtD
Temsirolimus—MTOR—appendage—germ cell cancer	0.00636	0.0782	CbGeAlD
Temsirolimus—MTOR—blood vessel—germ cell cancer	0.00354	0.0435	CbGeAlD
Temsirolimus—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00277	0.0705	CbGpPWpGaD
Temsirolimus—MTOR—neck—germ cell cancer	0.00253	0.0311	CbGeAlD
Temsirolimus—FKBP1A—neck—germ cell cancer	0.00228	0.028	CbGeAlD
Temsirolimus—MTOR—embryo—germ cell cancer	0.00211	0.026	CbGeAlD
Temsirolimus—FKBP1A—trigeminal ganglion—germ cell cancer	0.00197	0.0242	CbGeAlD
Temsirolimus—MTOR—brainstem—germ cell cancer	0.00193	0.0238	CbGeAlD
Temsirolimus—CYP3A4—urine—germ cell cancer	0.00192	0.0236	CbGeAlD
Temsirolimus—CYP2D6—urine—germ cell cancer	0.00189	0.0232	CbGeAlD
Temsirolimus—MTOR—eye—germ cell cancer	0.00188	0.0232	CbGeAlD
Temsirolimus—MTOR—retina—germ cell cancer	0.00187	0.0229	CbGeAlD
Temsirolimus—MTOR—telencephalon—germ cell cancer	0.00172	0.0211	CbGeAlD
Temsirolimus—FKBP1A—eye—germ cell cancer	0.00169	0.0208	CbGeAlD
Temsirolimus—FKBP1A—retina—germ cell cancer	0.00168	0.0206	CbGeAlD
Temsirolimus—MTOR—skin of body—germ cell cancer	0.00164	0.0201	CbGeAlD
Temsirolimus—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00159	0.0405	CbGpPWpGaD
Temsirolimus—FKBP1A—telencephalon—germ cell cancer	0.00154	0.019	CbGeAlD
Temsirolimus—FKBP1A—skin of body—germ cell cancer	0.00147	0.0181	CbGeAlD
Temsirolimus—FKBP1A—decidua—germ cell cancer	0.00146	0.018	CbGeAlD
Temsirolimus—MTOR—gonad—germ cell cancer	0.00143	0.0176	CbGeAlD
Temsirolimus—MTOR—uterus—germ cell cancer	0.00142	0.0175	CbGeAlD
Temsirolimus—MTOR—pituitary gland—germ cell cancer	0.0014	0.0172	CbGeAlD
Temsirolimus—FKBP1A—gonad—germ cell cancer	0.00129	0.0158	CbGeAlD
Temsirolimus—FKBP1A—uterus—germ cell cancer	0.00128	0.0157	CbGeAlD
Temsirolimus—FKBP1A—pituitary gland—germ cell cancer	0.00126	0.0155	CbGeAlD
Temsirolimus—MTOR—adrenal gland—germ cell cancer	0.00125	0.0154	CbGeAlD
Temsirolimus—FKBP1A—medulla oblongata—germ cell cancer	0.00121	0.0149	CbGeAlD
Temsirolimus—MTOR—bone marrow—germ cell cancer	0.00121	0.0149	CbGeAlD
Temsirolimus—CYP3A7—endocrine gland—germ cell cancer	0.0012	0.0148	CbGeAlD
Temsirolimus—MTOR—spinal cord—germ cell cancer	0.0012	0.0148	CbGeAlD
Temsirolimus—MTOR—female gonad—germ cell cancer	0.00116	0.0143	CbGeAlD
Temsirolimus—FKBP1A—adrenal gland—germ cell cancer	0.00112	0.0138	CbGeAlD
Temsirolimus—FKBP1A—midbrain—germ cell cancer	0.00111	0.0136	CbGeAlD
Temsirolimus—CYP3A7—Metapathway biotransformation—NAT9—germ cell cancer	0.0011	0.0281	CbGpPWpGaD
Temsirolimus—FKBP1A—bone marrow—germ cell cancer	0.00109	0.0134	CbGeAlD
Temsirolimus—MTOR—endocrine gland—germ cell cancer	0.00108	0.0133	CbGeAlD
Temsirolimus—FKBP1A—spinal cord—germ cell cancer	0.00108	0.0133	CbGeAlD
Temsirolimus—MTOR—head—germ cell cancer	0.00107	0.0131	CbGeAlD
Temsirolimus—FKBP1A—female gonad—germ cell cancer	0.00105	0.0129	CbGeAlD
Temsirolimus—MTOR—testis—germ cell cancer	0.00103	0.0127	CbGeAlD
Temsirolimus—FKBP1A—endocrine gland—germ cell cancer	0.000974	0.012	CbGeAlD
Temsirolimus—FKBP1A—head—germ cell cancer	0.000961	0.0118	CbGeAlD
Temsirolimus—MTOR—cerebellum—germ cell cancer	0.000954	0.0117	CbGeAlD
Temsirolimus—FKBP1A—testis—germ cell cancer	0.000929	0.0114	CbGeAlD
Temsirolimus—FKBP1A—cerebellum—germ cell cancer	0.000858	0.0105	CbGeAlD
Temsirolimus—CYP3A5—Metapathway biotransformation—NAT9—germ cell cancer	0.000797	0.0203	CbGpPWpGaD
Temsirolimus—MTOR—brain—germ cell cancer	0.000775	0.00952	CbGeAlD
Temsirolimus—MTOR—lymph node—germ cell cancer	0.000749	0.0092	CbGeAlD
Temsirolimus—ABCB1—blood vessel—germ cell cancer	0.000736	0.00905	CbGeAlD
Temsirolimus—FKBP1A—brain—germ cell cancer	0.000697	0.00857	CbGeAlD
Temsirolimus—FKBP1A—lymph node—germ cell cancer	0.000673	0.00828	CbGeAlD
Temsirolimus—MTOR—Cellular responses to stress—PHC1—germ cell cancer	0.000648	0.0165	CbGpPWpGaD
Temsirolimus—MTOR—EGFR-dependent Endothelin signaling events—HRAS—germ cell cancer	0.000567	0.0145	CbGpPWpGaD
Temsirolimus—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	0.000567	0.0144	CbGpPWpGaD
Temsirolimus—CYP2D6—brainstem—germ cell cancer	0.000559	0.00688	CbGeAlD
Temsirolimus—CYP2D6—telencephalon—germ cell cancer	0.000497	0.0061	CbGeAlD
Temsirolimus—Angiopathy—Ifosfamide—germ cell cancer	0.000471	0.00195	CcSEcCtD
Temsirolimus—Immune system disorder—Ifosfamide—germ cell cancer	0.000469	0.00194	CcSEcCtD
Temsirolimus—Mediastinal disorder—Ifosfamide—germ cell cancer	0.000468	0.00194	CcSEcCtD
Temsirolimus—Chills—Ifosfamide—germ cell cancer	0.000466	0.00193	CcSEcCtD
Temsirolimus—MTOR—PI3K Cascade—FGF4—germ cell cancer	0.000464	0.0118	CbGpPWpGaD
Temsirolimus—Cough—Bleomycin—germ cell cancer	0.000462	0.00191	CcSEcCtD
Temsirolimus—Pneumonia—Etoposide—germ cell cancer	0.00046	0.0019	CcSEcCtD
Temsirolimus—Infestation NOS—Etoposide—germ cell cancer	0.000457	0.00189	CcSEcCtD
Temsirolimus—Infestation—Etoposide—germ cell cancer	0.000457	0.00189	CcSEcCtD
Temsirolimus—Anaemia—Dactinomycin—germ cell cancer	0.000456	0.00189	CcSEcCtD
Temsirolimus—CYP3A5—female gonad—germ cell cancer	0.000456	0.00561	CbGeAlD
Temsirolimus—Mental disorder—Ifosfamide—germ cell cancer	0.000455	0.00189	CcSEcCtD
Temsirolimus—ABCB1—trigeminal ganglion—germ cell cancer	0.000455	0.00559	CbGeAlD
Temsirolimus—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000453	0.00188	CcSEcCtD
Temsirolimus—Malnutrition—Ifosfamide—germ cell cancer	0.000452	0.00187	CcSEcCtD
Temsirolimus—Erythema—Ifosfamide—germ cell cancer	0.000452	0.00187	CcSEcCtD
Temsirolimus—Chest pain—Bleomycin—germ cell cancer	0.000451	0.00187	CcSEcCtD
Temsirolimus—Myalgia—Bleomycin—germ cell cancer	0.000451	0.00187	CcSEcCtD
Temsirolimus—Renal failure—Etoposide—germ cell cancer	0.000449	0.00186	CcSEcCtD
Temsirolimus—Stomatitis—Etoposide—germ cell cancer	0.000446	0.00185	CcSEcCtD
Temsirolimus—Decreased appetite—Vinblastine—germ cell cancer	0.000445	0.00184	CcSEcCtD
Temsirolimus—Bladder pain—Methotrexate—germ cell cancer	0.000443	0.00183	CcSEcCtD
Temsirolimus—Mouth ulceration—Methotrexate—germ cell cancer	0.000443	0.00183	CcSEcCtD
Temsirolimus—Ecchymosis—Methotrexate—germ cell cancer	0.000443	0.00183	CcSEcCtD
Temsirolimus—Urinary tract disorder—Cisplatin—germ cell cancer	0.000442	0.00183	CcSEcCtD
Temsirolimus—Leukopenia—Dactinomycin—germ cell cancer	0.000442	0.00183	CcSEcCtD
Temsirolimus—Connective tissue disorder—Cisplatin—germ cell cancer	0.00044	0.00182	CcSEcCtD
Temsirolimus—ABCB1—embryo—germ cell cancer	0.000439	0.0054	CbGeAlD
Temsirolimus—Urethral disorder—Cisplatin—germ cell cancer	0.000439	0.00182	CcSEcCtD
Temsirolimus—Pain—Vinblastine—germ cell cancer	0.000437	0.00181	CcSEcCtD
Temsirolimus—Constipation—Vinblastine—germ cell cancer	0.000437	0.00181	CcSEcCtD
Temsirolimus—Oedema—Bleomycin—germ cell cancer	0.000432	0.00179	CcSEcCtD
Temsirolimus—Anaphylactic shock—Bleomycin—germ cell cancer	0.000432	0.00179	CcSEcCtD
Temsirolimus—Infection—Bleomycin—germ cell cancer	0.000429	0.00178	CcSEcCtD
Temsirolimus—Sepsis—Methotrexate—germ cell cancer	0.000425	0.00176	CcSEcCtD
Temsirolimus—CYP3A5—endocrine gland—germ cell cancer	0.000424	0.00521	CbGeAlD
Temsirolimus—Thrombocytopenia—Bleomycin—germ cell cancer	0.000423	0.00175	CcSEcCtD
Temsirolimus—Myalgia—Dactinomycin—germ cell cancer	0.00042	0.00174	CcSEcCtD
Temsirolimus—Eye disorder—Cisplatin—germ cell cancer	0.000419	0.00173	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000418	0.00173	CcSEcCtD
Temsirolimus—Anaemia—Ifosfamide—germ cell cancer	0.000418	0.00173	CcSEcCtD
Temsirolimus—Cardiac disorder—Cisplatin—germ cell cancer	0.000416	0.00172	CcSEcCtD
Temsirolimus—Angioedema—Ifosfamide—germ cell cancer	0.000413	0.00171	CcSEcCtD
Temsirolimus—Anorexia—Bleomycin—germ cell cancer	0.000412	0.00171	CcSEcCtD
Temsirolimus—Thrombophlebitis—Methotrexate—germ cell cancer	0.00041	0.0017	CcSEcCtD
Temsirolimus—Diabetes mellitus—Methotrexate—germ cell cancer	0.000409	0.00169	CcSEcCtD
Temsirolimus—Urinary tract disorder—Etoposide—germ cell cancer	0.000405	0.00168	CcSEcCtD
Temsirolimus—Leukopenia—Ifosfamide—germ cell cancer	0.000405	0.00168	CcSEcCtD
Temsirolimus—Immune system disorder—Cisplatin—germ cell cancer	0.000405	0.00168	CcSEcCtD
Temsirolimus—Abdominal pain—Vinblastine—germ cell cancer	0.000404	0.00167	CcSEcCtD
Temsirolimus—Mediastinal disorder—Cisplatin—germ cell cancer	0.000404	0.00167	CcSEcCtD
Temsirolimus—Oedema—Dactinomycin—germ cell cancer	0.000403	0.00167	CcSEcCtD
Temsirolimus—Urethral disorder—Etoposide—germ cell cancer	0.000402	0.00167	CcSEcCtD
Temsirolimus—Infection—Dactinomycin—germ cell cancer	0.0004	0.00166	CcSEcCtD
Temsirolimus—Cough—Ifosfamide—germ cell cancer	0.000395	0.00164	CcSEcCtD
Temsirolimus—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000394	0.00163	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000394	0.00163	CcSEcCtD
Temsirolimus—Convulsion—Ifosfamide—germ cell cancer	0.000392	0.00162	CcSEcCtD
Temsirolimus—Hypertension—Ifosfamide—germ cell cancer	0.000391	0.00162	CcSEcCtD
Temsirolimus—Malnutrition—Cisplatin—germ cell cancer	0.00039	0.00162	CcSEcCtD
Temsirolimus—Erythema—Cisplatin—germ cell cancer	0.00039	0.00162	CcSEcCtD
Temsirolimus—MTOR—IRS-mediated signalling—FGF4—germ cell cancer	0.000388	0.0099	CbGpPWpGaD
Temsirolimus—ABCB1—retina—germ cell cancer	0.000388	0.00477	CbGeAlD
Temsirolimus—Erythema multiforme—Etoposide—germ cell cancer	0.000388	0.00161	CcSEcCtD
Temsirolimus—Dyspnoea—Bleomycin—germ cell cancer	0.000385	0.0016	CcSEcCtD
Temsirolimus—Myalgia—Ifosfamide—germ cell cancer	0.000385	0.0016	CcSEcCtD
Temsirolimus—Arthralgia—Ifosfamide—germ cell cancer	0.000385	0.0016	CcSEcCtD
Temsirolimus—Chest pain—Ifosfamide—germ cell cancer	0.000385	0.0016	CcSEcCtD
Temsirolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—FGF4—germ cell cancer	0.000385	0.00981	CbGpPWpGaD
Temsirolimus—Anorexia—Dactinomycin—germ cell cancer	0.000384	0.00159	CcSEcCtD
Temsirolimus—Eye disorder—Etoposide—germ cell cancer	0.000384	0.00159	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000382	0.00158	CcSEcCtD
Temsirolimus—Cardiac disorder—Etoposide—germ cell cancer	0.000381	0.00158	CcSEcCtD
Temsirolimus—MTOR—IRS-related events—FGF4—germ cell cancer	0.000378	0.00963	CbGpPWpGaD
Temsirolimus—Hypersensitivity—Vinblastine—germ cell cancer	0.000377	0.00156	CcSEcCtD
Temsirolimus—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000377	0.00156	CcSEcCtD
Temsirolimus—Decreased appetite—Bleomycin—germ cell cancer	0.000376	0.00156	CcSEcCtD
Temsirolimus—MTOR—IRS-related events triggered by IGF1R—FGF4—germ cell cancer	0.000374	0.00954	CbGpPWpGaD
Temsirolimus—Angiopathy—Etoposide—germ cell cancer	0.000372	0.00154	CcSEcCtD
Temsirolimus—Immune system disorder—Etoposide—germ cell cancer	0.000371	0.00154	CcSEcCtD
Temsirolimus—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000371	0.00944	CbGpPWpGaD
Temsirolimus—Mediastinal disorder—Etoposide—germ cell cancer	0.00037	0.00153	CcSEcCtD
Temsirolimus—Pain—Bleomycin—germ cell cancer	0.000369	0.00153	CcSEcCtD
Temsirolimus—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000369	0.00153	CcSEcCtD
Temsirolimus—Oedema—Ifosfamide—germ cell cancer	0.000369	0.00153	CcSEcCtD
Temsirolimus—Chills—Etoposide—germ cell cancer	0.000368	0.00153	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000367	0.00152	CcSEcCtD
Temsirolimus—Asthenia—Vinblastine—germ cell cancer	0.000367	0.00152	CcSEcCtD
Temsirolimus—Infection—Ifosfamide—germ cell cancer	0.000367	0.00152	CcSEcCtD
Temsirolimus—MTOR—Insulin receptor signalling cascade—FGF4—germ cell cancer	0.000365	0.00929	CbGpPWpGaD
Temsirolimus—MTOR—IGF1R signaling cascade—FGF4—germ cell cancer	0.000365	0.00929	CbGpPWpGaD
Temsirolimus—Nervous system disorder—Ifosfamide—germ cell cancer	0.000362	0.0015	CcSEcCtD
Temsirolimus—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000361	0.0015	CcSEcCtD
Temsirolimus—Anaemia—Cisplatin—germ cell cancer	0.00036	0.00149	CcSEcCtD
Temsirolimus—Skin disorder—Ifosfamide—germ cell cancer	0.000359	0.00149	CcSEcCtD
Temsirolimus—ABCB1—telencephalon—germ cell cancer	0.000357	0.00439	CbGeAlD
Temsirolimus—Anorexia—Ifosfamide—germ cell cancer	0.000352	0.00146	CcSEcCtD
Temsirolimus—Decreased appetite—Dactinomycin—germ cell cancer	0.00035	0.00145	CcSEcCtD
Temsirolimus—Diarrhoea—Vinblastine—germ cell cancer	0.00035	0.00145	CcSEcCtD
Temsirolimus—Dysgeusia—Etoposide—germ cell cancer	0.00035	0.00145	CcSEcCtD
Temsirolimus—Leukopenia—Cisplatin—germ cell cancer	0.000349	0.00145	CcSEcCtD
Temsirolimus—Fatigue—Dactinomycin—germ cell cancer	0.000347	0.00144	CcSEcCtD
Temsirolimus—MTOR—PI-3K cascade—FGF4—germ cell cancer	0.000347	0.00883	CbGpPWpGaD
Temsirolimus—Back pain—Etoposide—germ cell cancer	0.000346	0.00143	CcSEcCtD
Temsirolimus—Pain—Dactinomycin—germ cell cancer	0.000345	0.00143	CcSEcCtD
Temsirolimus—Body temperature increased—Bleomycin—germ cell cancer	0.000341	0.00141	CcSEcCtD
Temsirolimus—ABCB1—decidua—germ cell cancer	0.000339	0.00416	CbGeAlD
Temsirolimus—MTOR—PI3K/AKT activation—FGF4—germ cell cancer	0.000338	0.00862	CbGpPWpGaD
Temsirolimus—Dizziness—Vinblastine—germ cell cancer	0.000338	0.0014	CcSEcCtD
Temsirolimus—Convulsion—Cisplatin—germ cell cancer	0.000338	0.0014	CcSEcCtD
Temsirolimus—CYP2D6—female gonad—germ cell cancer	0.000337	0.00414	CbGeAlD
Temsirolimus—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000336	0.00139	CcSEcCtD
Temsirolimus—MTOR—BDNF signaling pathway—ALPL—germ cell cancer	0.000336	0.00857	CbGpPWpGaD
Temsirolimus—MTOR—GAB1 signalosome—FGF4—germ cell cancer	0.000336	0.00856	CbGpPWpGaD
Temsirolimus—Myalgia—Cisplatin—germ cell cancer	0.000332	0.00138	CcSEcCtD
Temsirolimus—Anxiety—Cisplatin—germ cell cancer	0.000331	0.00137	CcSEcCtD
Temsirolimus—Anaemia—Etoposide—germ cell cancer	0.00033	0.00137	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00033	0.00137	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000329	0.00136	CcSEcCtD
Temsirolimus—Dyspnoea—Ifosfamide—germ cell cancer	0.000329	0.00136	CcSEcCtD
Temsirolimus—Somnolence—Ifosfamide—germ cell cancer	0.000328	0.00136	CcSEcCtD
Temsirolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—FGF4—germ cell cancer	0.000328	0.00836	CbGpPWpGaD
Temsirolimus—Vomiting—Vinblastine—germ cell cancer	0.000325	0.00135	CcSEcCtD
Temsirolimus—Decreased appetite—Ifosfamide—germ cell cancer	0.000321	0.00133	CcSEcCtD
Temsirolimus—Headache—Vinblastine—germ cell cancer	0.00032	0.00133	CcSEcCtD
Temsirolimus—Leukopenia—Etoposide—germ cell cancer	0.00032	0.00132	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000319	0.00132	CcSEcCtD
Temsirolimus—Abdominal pain—Dactinomycin—germ cell cancer	0.000318	0.00132	CcSEcCtD
Temsirolimus—Body temperature increased—Dactinomycin—germ cell cancer	0.000318	0.00132	CcSEcCtD
Temsirolimus—Fatigue—Ifosfamide—germ cell cancer	0.000318	0.00132	CcSEcCtD
Temsirolimus—Anaphylactic shock—Cisplatin—germ cell cancer	0.000318	0.00132	CcSEcCtD
Temsirolimus—Oedema—Cisplatin—germ cell cancer	0.000318	0.00132	CcSEcCtD
Temsirolimus—CYP3A4—endocrine gland—germ cell cancer	0.000318	0.00391	CbGeAlD
Temsirolimus—Hypersensitivity—Bleomycin—germ cell cancer	0.000318	0.00132	CcSEcCtD
Temsirolimus—Infection—Cisplatin—germ cell cancer	0.000316	0.00131	CcSEcCtD
Temsirolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—KITLG—germ cell cancer	0.000316	0.00806	CbGpPWpGaD
Temsirolimus—Constipation—Ifosfamide—germ cell cancer	0.000316	0.00131	CcSEcCtD
Temsirolimus—Pain—Ifosfamide—germ cell cancer	0.000316	0.00131	CcSEcCtD
Temsirolimus—CYP2D6—endocrine gland—germ cell cancer	0.000313	0.00385	CbGeAlD
Temsirolimus—Nervous system disorder—Cisplatin—germ cell cancer	0.000312	0.00129	CcSEcCtD
Temsirolimus—Cough—Etoposide—germ cell cancer	0.000312	0.00129	CcSEcCtD
Temsirolimus—Thrombocytopenia—Cisplatin—germ cell cancer	0.000312	0.00129	CcSEcCtD
Temsirolimus—Asthenia—Bleomycin—germ cell cancer	0.00031	0.00128	CcSEcCtD
Temsirolimus—Convulsion—Etoposide—germ cell cancer	0.00031	0.00128	CcSEcCtD
Temsirolimus—CYP2D6—head—germ cell cancer	0.000309	0.0038	CbGeAlD
Temsirolimus—Skin disorder—Cisplatin—germ cell cancer	0.000309	0.00128	CcSEcCtD
Temsirolimus—Hypertension—Etoposide—germ cell cancer	0.000308	0.00128	CcSEcCtD
Temsirolimus—Pruritus—Bleomycin—germ cell cancer	0.000306	0.00127	CcSEcCtD
Temsirolimus—Chest pain—Etoposide—germ cell cancer	0.000304	0.00126	CcSEcCtD
Temsirolimus—Nausea—Vinblastine—germ cell cancer	0.000304	0.00126	CcSEcCtD
Temsirolimus—Anorexia—Cisplatin—germ cell cancer	0.000303	0.00126	CcSEcCtD
Temsirolimus—MTOR—Signaling by Insulin receptor—FGF4—germ cell cancer	0.000303	0.00772	CbGpPWpGaD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000302	0.00125	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000302	0.00125	CcSEcCtD
Temsirolimus—CYP2D6—testis—germ cell cancer	0.000299	0.00367	CbGeAlD
Temsirolimus—ABCB1—gonad—germ cell cancer	0.000298	0.00366	CbGeAlD
Temsirolimus—Hypersensitivity—Dactinomycin—germ cell cancer	0.000297	0.00123	CcSEcCtD
Temsirolimus—ABCB1—uterus—germ cell cancer	0.000296	0.00364	CbGeAlD
Temsirolimus—Abdominal pain—Ifosfamide—germ cell cancer	0.000292	0.00121	CcSEcCtD
Temsirolimus—Body temperature increased—Ifosfamide—germ cell cancer	0.000292	0.00121	CcSEcCtD
Temsirolimus—Anaphylactic shock—Etoposide—germ cell cancer	0.000292	0.00121	CcSEcCtD
Temsirolimus—ABCB1—pituitary gland—germ cell cancer	0.000291	0.00358	CbGeAlD
Temsirolimus—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00029	0.0012	CcSEcCtD
Temsirolimus—Infection—Etoposide—germ cell cancer	0.00029	0.0012	CcSEcCtD
Temsirolimus—Asthenia—Dactinomycin—germ cell cancer	0.000289	0.0012	CcSEcCtD
Temsirolimus—Neutropenia—Methotrexate—germ cell cancer	0.000287	0.00119	CcSEcCtD
Temsirolimus—Dysuria—Methotrexate—germ cell cancer	0.000287	0.00119	CcSEcCtD
Temsirolimus—Thrombocytopenia—Etoposide—germ cell cancer	0.000285	0.00118	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000285	0.00118	CcSEcCtD
Temsirolimus—MTOR—PI-3K cascade—KITLG—germ cell cancer	0.000285	0.00726	CbGpPWpGaD
Temsirolimus—Dyspnoea—Cisplatin—germ cell cancer	0.000284	0.00118	CcSEcCtD
Temsirolimus—MTOR—PI3K Cascade—FGFR3—germ cell cancer	0.000283	0.00723	CbGpPWpGaD
Temsirolimus—Skin disorder—Etoposide—germ cell cancer	0.000283	0.00117	CcSEcCtD
Temsirolimus—ABCB1—medulla oblongata—germ cell cancer	0.000281	0.00345	CbGeAlD
Temsirolimus—MTOR—PI3K/AKT activation—KITLG—germ cell cancer	0.000278	0.00709	CbGpPWpGaD
Temsirolimus—Anorexia—Etoposide—germ cell cancer	0.000278	0.00115	CcSEcCtD
Temsirolimus—Decreased appetite—Cisplatin—germ cell cancer	0.000277	0.00115	CcSEcCtD
Temsirolimus—CYP2D6—cerebellum—germ cell cancer	0.000276	0.00339	CbGeAlD
Temsirolimus—MTOR—GAB1 signalosome—KITLG—germ cell cancer	0.000276	0.00703	CbGpPWpGaD
Temsirolimus—Diarrhoea—Dactinomycin—germ cell cancer	0.000276	0.00114	CcSEcCtD
Temsirolimus—Pneumonia—Methotrexate—germ cell cancer	0.000275	0.00114	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000275	0.00114	CcSEcCtD
Temsirolimus—Vomiting—Bleomycin—germ cell cancer	0.000275	0.00114	CcSEcCtD
Temsirolimus—Infestation NOS—Methotrexate—germ cell cancer	0.000274	0.00113	CcSEcCtD
Temsirolimus—Infestation—Methotrexate—germ cell cancer	0.000274	0.00113	CcSEcCtD
Temsirolimus—Depression—Methotrexate—germ cell cancer	0.000273	0.00113	CcSEcCtD
Temsirolimus—Rash—Bleomycin—germ cell cancer	0.000272	0.00113	CcSEcCtD
Temsirolimus—Pain—Cisplatin—germ cell cancer	0.000272	0.00113	CcSEcCtD
Temsirolimus—Dermatitis—Bleomycin—germ cell cancer	0.000272	0.00113	CcSEcCtD
Temsirolimus—Hypersensitivity—Ifosfamide—germ cell cancer	0.000272	0.00113	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000271	0.00112	CcSEcCtD
Temsirolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—KITLG—germ cell cancer	0.000269	0.00687	CbGpPWpGaD
Temsirolimus—Renal failure—Methotrexate—germ cell cancer	0.000269	0.00112	CcSEcCtD
Temsirolimus—Stomatitis—Methotrexate—germ cell cancer	0.000267	0.00111	CcSEcCtD
Temsirolimus—Conjunctivitis—Methotrexate—germ cell cancer	0.000266	0.0011	CcSEcCtD
Temsirolimus—Asthenia—Ifosfamide—germ cell cancer	0.000265	0.0011	CcSEcCtD
Temsirolimus—Pruritus—Ifosfamide—germ cell cancer	0.000261	0.00108	CcSEcCtD
Temsirolimus—Haematuria—Methotrexate—germ cell cancer	0.000261	0.00108	CcSEcCtD
Temsirolimus—Dyspnoea—Etoposide—germ cell cancer	0.00026	0.00108	CcSEcCtD
Temsirolimus—ABCB1—adrenal gland—germ cell cancer	0.00026	0.00319	CbGeAlD
Temsirolimus—Somnolence—Etoposide—germ cell cancer	0.000259	0.00107	CcSEcCtD
Temsirolimus—MTOR—Signaling by SCF-KIT—FGF4—germ cell cancer	0.000259	0.0066	CbGpPWpGaD
Temsirolimus—Epistaxis—Methotrexate—germ cell cancer	0.000258	0.00107	CcSEcCtD
Temsirolimus—Nausea—Bleomycin—germ cell cancer	0.000257	0.00106	CcSEcCtD
Temsirolimus—ABCB1—midbrain—germ cell cancer	0.000256	0.00315	CbGeAlD
Temsirolimus—Vomiting—Dactinomycin—germ cell cancer	0.000256	0.00106	CcSEcCtD
Temsirolimus—Rash—Dactinomycin—germ cell cancer	0.000254	0.00105	CcSEcCtD
Temsirolimus—Decreased appetite—Etoposide—germ cell cancer	0.000253	0.00105	CcSEcCtD
Temsirolimus—Diarrhoea—Ifosfamide—germ cell cancer	0.000253	0.00105	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000252	0.00104	CcSEcCtD
Temsirolimus—Body temperature increased—Cisplatin—germ cell cancer	0.000252	0.00104	CcSEcCtD
Temsirolimus—Fatigue—Etoposide—germ cell cancer	0.000251	0.00104	CcSEcCtD
Temsirolimus—ABCB1—bone marrow—germ cell cancer	0.000251	0.00309	CbGeAlD
Temsirolimus—ABCB1—spinal cord—germ cell cancer	0.00025	0.00308	CbGeAlD
Temsirolimus—Constipation—Etoposide—germ cell cancer	0.000249	0.00103	CcSEcCtD
Temsirolimus—Pain—Etoposide—germ cell cancer	0.000249	0.00103	CcSEcCtD
Temsirolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—MYC—germ cell cancer	0.000249	0.00634	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—FGF4—germ cell cancer	0.000248	0.00632	CbGpPWpGaD
Temsirolimus—Dizziness—Ifosfamide—germ cell cancer	0.000244	0.00101	CcSEcCtD
Temsirolimus—Pharyngitis—Methotrexate—germ cell cancer	0.000244	0.00101	CcSEcCtD
Temsirolimus—MTOR—Signaling by ERBB4—FGF4—germ cell cancer	0.000244	0.00622	CbGpPWpGaD
Temsirolimus—Urinary tract disorder—Methotrexate—germ cell cancer	0.000243	0.00101	CcSEcCtD
Temsirolimus—ABCB1—female gonad—germ cell cancer	0.000242	0.00298	CbGeAlD
Temsirolimus—Urethral disorder—Methotrexate—germ cell cancer	0.000241	0.000998	CcSEcCtD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—HRAS—germ cell cancer	0.00024	0.00613	CbGpPWpGaD
Temsirolimus—Nausea—Dactinomycin—germ cell cancer	0.000239	0.000991	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Etoposide—germ cell cancer	0.000238	0.000988	CcSEcCtD
Temsirolimus—MTOR—IRS-mediated signalling—FGFR3—germ cell cancer	0.000237	0.00604	CbGpPWpGaD
Temsirolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—FGFR3—germ cell cancer	0.000235	0.00599	CbGpPWpGaD
Temsirolimus—Vomiting—Ifosfamide—germ cell cancer	0.000235	0.000972	CcSEcCtD
Temsirolimus—Hypersensitivity—Cisplatin—germ cell cancer	0.000234	0.000971	CcSEcCtD
Temsirolimus—MTOR—IL2 signaling events mediated by PI3K—MYC—germ cell cancer	0.000233	0.00594	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—FGF4—germ cell cancer	0.000233	0.00594	CbGpPWpGaD
Temsirolimus—Rash—Ifosfamide—germ cell cancer	0.000233	0.000964	CcSEcCtD
Temsirolimus—Dermatitis—Ifosfamide—germ cell cancer	0.000233	0.000963	CcSEcCtD
Temsirolimus—Erythema multiforme—Methotrexate—germ cell cancer	0.000232	0.000963	CcSEcCtD
Temsirolimus—MTOR—Signaling by FGFR—FGF4—germ cell cancer	0.000232	0.00591	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—FGF4—germ cell cancer	0.000231	0.00588	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events—FGFR3—germ cell cancer	0.000231	0.00588	CbGpPWpGaD
Temsirolimus—Body temperature increased—Etoposide—germ cell cancer	0.000231	0.000955	CcSEcCtD
Temsirolimus—Abdominal pain—Etoposide—germ cell cancer	0.000231	0.000955	CcSEcCtD
Temsirolimus—Eye disorder—Methotrexate—germ cell cancer	0.00023	0.000952	CcSEcCtD
Temsirolimus—MTOR—DAP12 signaling—FGF4—germ cell cancer	0.00023	0.00585	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events triggered by IGF1R—FGFR3—germ cell cancer	0.000229	0.00583	CbGpPWpGaD
Temsirolimus—Asthenia—Cisplatin—germ cell cancer	0.000228	0.000946	CcSEcCtD
Temsirolimus—Cardiac disorder—Methotrexate—germ cell cancer	0.000228	0.000945	CcSEcCtD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—FGF4—germ cell cancer	0.000226	0.00577	CbGpPWpGaD
Temsirolimus—ABCB1—endocrine gland—germ cell cancer	0.000225	0.00277	CbGeAlD
Temsirolimus—CYP2D6—brain—germ cell cancer	0.000224	0.00275	CbGeAlD
Temsirolimus—Angiopathy—Methotrexate—germ cell cancer	0.000223	0.000924	CcSEcCtD
Temsirolimus—MTOR—Insulin receptor signalling cascade—FGFR3—germ cell cancer	0.000223	0.00567	CbGpPWpGaD
Temsirolimus—MTOR—IGF1R signaling cascade—FGFR3—germ cell cancer	0.000223	0.00567	CbGpPWpGaD
Temsirolimus—ABCB1—head—germ cell cancer	0.000222	0.00273	CbGeAlD
Temsirolimus—Immune system disorder—Methotrexate—germ cell cancer	0.000222	0.00092	CcSEcCtD
Temsirolimus—Mediastinal disorder—Methotrexate—germ cell cancer	0.000222	0.000918	CcSEcCtD
Temsirolimus—Chills—Methotrexate—germ cell cancer	0.000221	0.000914	CcSEcCtD
Temsirolimus—Nausea—Ifosfamide—germ cell cancer	0.000219	0.000908	CcSEcCtD
Temsirolimus—Diarrhoea—Cisplatin—germ cell cancer	0.000218	0.000902	CcSEcCtD
Temsirolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—HRAS—germ cell cancer	0.000216	0.00552	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—FGF4—germ cell cancer	0.000216	0.00551	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—FGF4—germ cell cancer	0.000216	0.00551	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—FGF4—germ cell cancer	0.000216	0.00551	CbGpPWpGaD
Temsirolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—KIT—germ cell cancer	0.000216	0.0055	CbGpPWpGaD
Temsirolimus—Mental disorder—Methotrexate—germ cell cancer	0.000215	0.000892	CcSEcCtD
Temsirolimus—ABCB1—testis—germ cell cancer	0.000215	0.00264	CbGeAlD
Temsirolimus—Hypersensitivity—Etoposide—germ cell cancer	0.000215	0.00089	CcSEcCtD
Temsirolimus—MTOR—Signaling by EGFR—FGF4—germ cell cancer	0.000214	0.00546	CbGpPWpGaD
Temsirolimus—Erythema—Methotrexate—germ cell cancer	0.000214	0.000887	CcSEcCtD
Temsirolimus—Malnutrition—Methotrexate—germ cell cancer	0.000214	0.000887	CcSEcCtD
Temsirolimus—MTOR—Signaling by SCF-KIT—KITLG—germ cell cancer	0.000213	0.00543	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—FGF4—germ cell cancer	0.000212	0.00541	CbGpPWpGaD
Temsirolimus—MTOR—PI-3K cascade—FGFR3—germ cell cancer	0.000212	0.00539	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—FGF4—germ cell cancer	0.000211	0.00538	CbGpPWpGaD
Temsirolimus—Dysgeusia—Methotrexate—germ cell cancer	0.00021	0.000868	CcSEcCtD
Temsirolimus—Asthenia—Etoposide—germ cell cancer	0.000209	0.000867	CcSEcCtD
Temsirolimus—Back pain—Methotrexate—germ cell cancer	0.000207	0.000858	CcSEcCtD
Temsirolimus—MTOR—LKB1 signaling events—MYC—germ cell cancer	0.000207	0.00527	CbGpPWpGaD
Temsirolimus—MTOR—PI3K/AKT activation—FGFR3—germ cell cancer	0.000207	0.00527	CbGpPWpGaD
Temsirolimus—Pruritus—Etoposide—germ cell cancer	0.000206	0.000855	CcSEcCtD
Temsirolimus—MTOR—GAB1 signalosome—FGFR3—germ cell cancer	0.000205	0.00522	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—KITLG—germ cell cancer	0.000204	0.00519	CbGpPWpGaD
Temsirolimus—Vomiting—Cisplatin—germ cell cancer	0.000202	0.000838	CcSEcCtD
Temsirolimus—Rash—Cisplatin—germ cell cancer	0.000201	0.000831	CcSEcCtD
Temsirolimus—MTOR—Alpha 6 Beta 4 signaling pathway—HRAS—germ cell cancer	0.000201	0.00511	CbGpPWpGaD
Temsirolimus—Dermatitis—Cisplatin—germ cell cancer	0.0002	0.000831	CcSEcCtD
Temsirolimus—MTOR—Signaling by ERBB4—KITLG—germ cell cancer	0.0002	0.00511	CbGpPWpGaD
Temsirolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—FGFR3—germ cell cancer	0.0002	0.0051	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—FGF4—germ cell cancer	0.0002	0.00509	CbGpPWpGaD
Temsirolimus—Diarrhoea—Etoposide—germ cell cancer	0.0002	0.000826	CcSEcCtD
Temsirolimus—ABCB1—cerebellum—germ cell cancer	0.000198	0.00244	CbGeAlD
Temsirolimus—Anaemia—Methotrexate—germ cell cancer	0.000198	0.000819	CcSEcCtD
Temsirolimus—MTOR—PI-3K cascade—KIT—germ cell cancer	0.000194	0.00495	CbGpPWpGaD
Temsirolimus—Dizziness—Etoposide—germ cell cancer	0.000193	0.000799	CcSEcCtD
Temsirolimus—MTOR—TSLP Signaling Pathway—MYC—germ cell cancer	0.000192	0.00491	CbGpPWpGaD
Temsirolimus—Leukopenia—Methotrexate—germ cell cancer	0.000192	0.000794	CcSEcCtD
Temsirolimus—MTOR—Downstream signal transduction—KITLG—germ cell cancer	0.000191	0.00488	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—FGF4—germ cell cancer	0.000191	0.00488	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—KITLG—germ cell cancer	0.00019	0.00485	CbGpPWpGaD
Temsirolimus—MTOR—PI3K/AKT activation—KIT—germ cell cancer	0.00019	0.00483	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—KITLG—germ cell cancer	0.00019	0.00483	CbGpPWpGaD
Temsirolimus—Nausea—Cisplatin—germ cell cancer	0.000189	0.000783	CcSEcCtD
Temsirolimus—MTOR—DAP12 signaling—KITLG—germ cell cancer	0.000189	0.00481	CbGpPWpGaD
Temsirolimus—MTOR—GAB1 signalosome—KIT—germ cell cancer	0.000188	0.0048	CbGpPWpGaD
Temsirolimus—Cough—Methotrexate—germ cell cancer	0.000187	0.000774	CcSEcCtD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—KITLG—germ cell cancer	0.000186	0.00474	CbGpPWpGaD
Temsirolimus—Convulsion—Methotrexate—germ cell cancer	0.000185	0.000768	CcSEcCtD
Temsirolimus—Vomiting—Etoposide—germ cell cancer	0.000185	0.000768	CcSEcCtD
Temsirolimus—MTOR—Signaling by Insulin receptor—FGFR3—germ cell cancer	0.000185	0.00471	CbGpPWpGaD
Temsirolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—germ cell cancer	0.000184	0.00469	CbGpPWpGaD
Temsirolimus—Rash—Etoposide—germ cell cancer	0.000184	0.000762	CcSEcCtD
Temsirolimus—Dermatitis—Etoposide—germ cell cancer	0.000184	0.000761	CcSEcCtD
Temsirolimus—Headache—Etoposide—germ cell cancer	0.000183	0.000757	CcSEcCtD
Temsirolimus—Myalgia—Methotrexate—germ cell cancer	0.000182	0.000755	CcSEcCtD
Temsirolimus—Arthralgia—Methotrexate—germ cell cancer	0.000182	0.000755	CcSEcCtD
Temsirolimus—Chest pain—Methotrexate—germ cell cancer	0.000182	0.000755	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000181	0.00075	CcSEcCtD
Temsirolimus—MTOR—CXCR3-mediated signaling events—HRAS—germ cell cancer	0.000179	0.00457	CbGpPWpGaD
Temsirolimus—MTOR—Wnt Signaling Pathway Netpath—MYC—germ cell cancer	0.000177	0.00452	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—KITLG—germ cell cancer	0.000177	0.00452	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—KITLG—germ cell cancer	0.000177	0.00452	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—KITLG—germ cell cancer	0.000177	0.00452	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—KITLG—germ cell cancer	0.000176	0.00448	CbGpPWpGaD
Temsirolimus—Anaphylactic shock—Methotrexate—germ cell cancer	0.000175	0.000724	CcSEcCtD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—KITLG—germ cell cancer	0.000174	0.00444	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—KITLG—germ cell cancer	0.000174	0.00442	CbGpPWpGaD
Temsirolimus—Infection—Methotrexate—germ cell cancer	0.000174	0.000719	CcSEcCtD
Temsirolimus—Nausea—Etoposide—germ cell cancer	0.000173	0.000718	CcSEcCtD
Temsirolimus—MTOR—ErbB Signaling Pathway—MYC—germ cell cancer	0.000172	0.00439	CbGpPWpGaD
Temsirolimus—Nervous system disorder—Methotrexate—germ cell cancer	0.000171	0.00071	CcSEcCtD
Temsirolimus—Thrombocytopenia—Methotrexate—germ cell cancer	0.000171	0.000708	CcSEcCtD
Temsirolimus—MTOR—LKB1 signaling events—TP53—germ cell cancer	0.00017	0.00433	CbGpPWpGaD
Temsirolimus—Skin disorder—Methotrexate—germ cell cancer	0.00017	0.000703	CcSEcCtD
Temsirolimus—MTOR—ErbB2/ErbB3 signaling events—HRAS—germ cell cancer	0.000169	0.0043	CbGpPWpGaD
Temsirolimus—Anorexia—Methotrexate—germ cell cancer	0.000166	0.00069	CcSEcCtD
Temsirolimus—MTOR—B Cell Activation—KITLG—germ cell cancer	0.000164	0.00419	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—MYC—germ cell cancer	0.000164	0.00418	CbGpPWpGaD
Temsirolimus—ABCB1—brain—germ cell cancer	0.000161	0.00198	CbGeAlD
Temsirolimus—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000159	0.000659	CcSEcCtD
Temsirolimus—MTOR—Signaling by SCF-KIT—FGFR3—germ cell cancer	0.000158	0.00403	CbGpPWpGaD
Temsirolimus—Insomnia—Methotrexate—germ cell cancer	0.000158	0.000654	CcSEcCtD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—KITLG—germ cell cancer	0.000157	0.00401	CbGpPWpGaD
Temsirolimus—ABCB1—lymph node—germ cell cancer	0.000156	0.00191	CbGeAlD
Temsirolimus—Dyspnoea—Methotrexate—germ cell cancer	0.000156	0.000645	CcSEcCtD
Temsirolimus—Somnolence—Methotrexate—germ cell cancer	0.000155	0.000643	CcSEcCtD
Temsirolimus—Decreased appetite—Methotrexate—germ cell cancer	0.000152	0.000629	CcSEcCtD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—FGFR3—germ cell cancer	0.000151	0.00386	CbGpPWpGaD
Temsirolimus—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000151	0.000625	CcSEcCtD
Temsirolimus—Fatigue—Methotrexate—germ cell cancer	0.000151	0.000624	CcSEcCtD
Temsirolimus—Pain—Methotrexate—germ cell cancer	0.000149	0.000619	CcSEcCtD
Temsirolimus—MTOR—Signaling by ERBB4—FGFR3—germ cell cancer	0.000149	0.0038	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—FGF4—germ cell cancer	0.000147	0.00375	CbGpPWpGaD
Temsirolimus—MTOR—TSH signaling pathway—MYC—germ cell cancer	0.000147	0.00374	CbGpPWpGaD
Temsirolimus—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	0.000146	0.00371	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—KIT—germ cell cancer	0.000145	0.0037	CbGpPWpGaD
Temsirolimus—MTOR—Regulation of Telomerase—MYC—germ cell cancer	0.000143	0.00365	CbGpPWpGaD
Temsirolimus—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000143	0.000592	CcSEcCtD
Temsirolimus—MTOR—Downstream signal transduction—FGFR3—germ cell cancer	0.000142	0.00363	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—FGFR3—germ cell cancer	0.000142	0.00361	CbGpPWpGaD
Temsirolimus—MTOR—ErbB Signaling Pathway—TP53—germ cell cancer	0.000141	0.00361	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—FGFR3—germ cell cancer	0.000141	0.00359	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—FGFR3—germ cell cancer	0.00014	0.00357	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—H2AFZ—germ cell cancer	0.00014	0.00357	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—SLC2A3—germ cell cancer	0.00014	0.00356	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—KIT—germ cell cancer	0.000139	0.00354	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—germ cell cancer	0.000138	0.00352	CbGpPWpGaD
Temsirolimus—Body temperature increased—Methotrexate—germ cell cancer	0.000138	0.000572	CcSEcCtD
Temsirolimus—Abdominal pain—Methotrexate—germ cell cancer	0.000138	0.000572	CcSEcCtD
Temsirolimus—MTOR—Signaling by ERBB4—KIT—germ cell cancer	0.000137	0.00349	CbGpPWpGaD
Temsirolimus—MTOR—ErbB Signaling Pathway—HRAS—germ cell cancer	0.000135	0.00345	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—TP53—germ cell cancer	0.000135	0.00343	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—FGFR3—germ cell cancer	0.000132	0.00336	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—FGFR3—germ cell cancer	0.000132	0.00336	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—FGFR3—germ cell cancer	0.000132	0.00336	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—FGFR3—germ cell cancer	0.000131	0.00333	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—KIT—germ cell cancer	0.000131	0.00333	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—KIT—germ cell cancer	0.00013	0.00331	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—FGFR3—germ cell cancer	0.00013	0.0033	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—KIT—germ cell cancer	0.000129	0.0033	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—FGFR3—germ cell cancer	0.000129	0.00329	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—KIT—germ cell cancer	0.000129	0.00328	CbGpPWpGaD
Temsirolimus—Hypersensitivity—Methotrexate—germ cell cancer	0.000129	0.000533	CcSEcCtD
Temsirolimus—MTOR—Adaptive Immune System—PVRL2—germ cell cancer	0.000128	0.00325	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—KIT—germ cell cancer	0.000127	0.00323	CbGpPWpGaD
Temsirolimus—Asthenia—Methotrexate—germ cell cancer	0.000125	0.000519	CcSEcCtD
Temsirolimus—Pruritus—Methotrexate—germ cell cancer	0.000124	0.000512	CcSEcCtD
Temsirolimus—MTOR—B Cell Activation—FGFR3—germ cell cancer	0.000122	0.00311	CbGpPWpGaD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—TP53—germ cell cancer	0.000122	0.00311	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—KIT—germ cell cancer	0.000121	0.00309	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—KIT—germ cell cancer	0.000121	0.00309	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—KIT—germ cell cancer	0.000121	0.00309	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—KITLG—germ cell cancer	0.000121	0.00308	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—KIT—germ cell cancer	0.00012	0.00306	CbGpPWpGaD
Temsirolimus—Diarrhoea—Methotrexate—germ cell cancer	0.000119	0.000495	CcSEcCtD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—KIT—germ cell cancer	0.000119	0.00303	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—KIT—germ cell cancer	0.000118	0.00302	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—FGFR3—germ cell cancer	0.000117	0.00298	CbGpPWpGaD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—HRAS—germ cell cancer	0.000117	0.00297	CbGpPWpGaD
Temsirolimus—MTOR—AMPK Signaling—TP53—germ cell cancer	0.000116	0.00296	CbGpPWpGaD
Temsirolimus—Dizziness—Methotrexate—germ cell cancer	0.000115	0.000478	CcSEcCtD
Temsirolimus—MTOR—mTOR signaling pathway—HRAS—germ cell cancer	0.000115	0.00294	CbGpPWpGaD
Temsirolimus—MTOR—TSH signaling pathway—HRAS—germ cell cancer	0.000115	0.00294	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—KIT—germ cell cancer	0.000112	0.00286	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	0.000111	0.00284	CbGpPWpGaD
Temsirolimus—Vomiting—Methotrexate—germ cell cancer	0.000111	0.00046	CcSEcCtD
Temsirolimus—Rash—Methotrexate—germ cell cancer	0.00011	0.000456	CcSEcCtD
Temsirolimus—Dermatitis—Methotrexate—germ cell cancer	0.00011	0.000456	CcSEcCtD
Temsirolimus—MTOR—CDC42 signaling events—HRAS—germ cell cancer	0.00011	0.0028	CbGpPWpGaD
Temsirolimus—Headache—Methotrexate—germ cell cancer	0.000109	0.000453	CcSEcCtD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—KIT—germ cell cancer	0.000107	0.00273	CbGpPWpGaD
Temsirolimus—MTOR—Leptin signaling pathway—HRAS—germ cell cancer	0.000104	0.00265	CbGpPWpGaD
Temsirolimus—Nausea—Methotrexate—germ cell cancer	0.000104	0.00043	CcSEcCtD
Temsirolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—germ cell cancer	9.88e-05	0.00252	CbGpPWpGaD
Temsirolimus—MTOR—IRS-mediated signalling—HRAS—germ cell cancer	9.41e-05	0.0024	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	9.24e-05	0.00236	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	9.15e-05	0.00233	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events—HRAS—germ cell cancer	9.15e-05	0.00233	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events triggered by IGF1R—HRAS—germ cell cancer	9.07e-05	0.00231	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—FGFR3—germ cell cancer	8.98e-05	0.00229	CbGpPWpGaD
Temsirolimus—MTOR—IGF1R signaling cascade—HRAS—germ cell cancer	8.83e-05	0.00225	CbGpPWpGaD
Temsirolimus—MTOR—Insulin receptor signalling cascade—HRAS—germ cell cancer	8.83e-05	0.00225	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—FGF4—germ cell cancer	8.39e-05	0.00214	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—TP53—germ cell cancer	8.31e-05	0.00212	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—KIT—germ cell cancer	8.25e-05	0.0021	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—FGF4—germ cell cancer	8.06e-05	0.00205	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—FGF4—germ cell cancer	8.02e-05	0.00205	CbGpPWpGaD
Temsirolimus—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	8.01e-05	0.00204	CbGpPWpGaD
Temsirolimus—MTOR—ErbB1 downstream signaling—HRAS—germ cell cancer	7.95e-05	0.00203	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—HRAS—germ cell cancer	7.95e-05	0.00203	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SLC2A3—germ cell cancer	7.86e-05	0.002	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—HRAS—germ cell cancer	7.83e-05	0.002	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PVRL2—germ cell cancer	7.74e-05	0.00197	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—MYC—germ cell cancer	7.56e-05	0.00193	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—HRAS—germ cell cancer	7.39e-05	0.00188	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—HRAS—germ cell cancer	7.34e-05	0.00187	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—H2AFZ—germ cell cancer	7.17e-05	0.00183	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—KITLG—germ cell cancer	6.89e-05	0.00176	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—KITLG—germ cell cancer	6.62e-05	0.00169	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—KITLG—germ cell cancer	6.59e-05	0.00168	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—OXT—germ cell cancer	6.58e-05	0.00168	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—HRAS—germ cell cancer	6.28e-05	0.0016	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—TP53—germ cell cancer	6.21e-05	0.00158	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—HRAS—germ cell cancer	6.17e-05	0.00157	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.05e-05	0.00154	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—HRAS—germ cell cancer	6.01e-05	0.00153	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.96e-05	0.00152	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—HRAS—germ cell cancer	5.91e-05	0.00151	CbGpPWpGaD
Temsirolimus—MTOR—Insulin Signaling—HRAS—germ cell cancer	5.67e-05	0.00145	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—HRAS—germ cell cancer	5.64e-05	0.00144	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FGF4—germ cell cancer	5.62e-05	0.00143	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—HRAS—germ cell cancer	5.62e-05	0.00143	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	5.62e-05	0.00143	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—HRAS—germ cell cancer	5.59e-05	0.00142	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—HRAS—germ cell cancer	5.56e-05	0.00142	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	5.48e-05	0.0014	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—HRAS—germ cell cancer	5.23e-05	0.00133	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	5.23e-05	0.00133	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—HRAS—germ cell cancer	5.23e-05	0.00133	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—SLC2A3—germ cell cancer	5.19e-05	0.00132	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—HRAS—germ cell cancer	5.19e-05	0.00132	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—HRAS—germ cell cancer	5.14e-05	0.00131	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—FGFR3—germ cell cancer	5.12e-05	0.00131	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—HRAS—germ cell cancer	5.12e-05	0.0013	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—SLC22A3—germ cell cancer	5.12e-05	0.0013	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—H2AFZ—germ cell cancer	5.02e-05	0.00128	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—FGFR3—germ cell cancer	4.92e-05	0.00125	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—FGFR3—germ cell cancer	4.9e-05	0.00125	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FGF4—germ cell cancer	4.89e-05	0.00125	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—HRAS—germ cell cancer	4.84e-05	0.00123	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—KIT—germ cell cancer	4.7e-05	0.0012	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	4.63e-05	0.00118	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—KITLG—germ cell cancer	4.62e-05	0.00118	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—KIT—germ cell cancer	4.52e-05	0.00115	CbGpPWpGaD
Temsirolimus—MTOR—Disease—FGF4—germ cell cancer	4.51e-05	0.00115	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—AVP—germ cell cancer	4.51e-05	0.00115	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—KIT—germ cell cancer	4.5e-05	0.00115	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CRABP1—germ cell cancer	4.17e-05	0.00106	CbGpPWpGaD
Temsirolimus—MTOR—Disease—H2AFZ—germ cell cancer	4.03e-05	0.00103	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—KITLG—germ cell cancer	4.02e-05	0.00102	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—TP53—germ cell cancer	3.97e-05	0.00101	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—SLC2A3—germ cell cancer	3.75e-05	0.000957	CbGpPWpGaD
Temsirolimus—MTOR—Disease—KITLG—germ cell cancer	3.71e-05	0.000945	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—OXT—germ cell cancer	3.7e-05	0.000944	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—SLC22A3—germ cell cancer	3.7e-05	0.000943	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—HRAS—germ cell cancer	3.56e-05	0.000909	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FGFR3—germ cell cancer	3.43e-05	0.000875	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FGF4—germ cell cancer	3.16e-05	0.000806	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—KIT—germ cell cancer	3.15e-05	0.000803	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CRABP1—germ cell cancer	3.01e-05	0.000768	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FGFR3—germ cell cancer	2.98e-05	0.000761	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SLC2A3—germ cell cancer	2.83e-05	0.000722	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—H2AFZ—germ cell cancer	2.82e-05	0.000719	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SLC22A3—germ cell cancer	2.79e-05	0.000711	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.79e-05	0.000711	CbGpPWpGaD
Temsirolimus—MTOR—Disease—FGFR3—germ cell cancer	2.76e-05	0.000702	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—KIT—germ cell cancer	2.74e-05	0.000698	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.7e-05	0.000688	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SLC2A3—germ cell cancer	2.67e-05	0.00068	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SLC22A3—germ cell cancer	2.63e-05	0.00067	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—KITLG—germ cell cancer	2.6e-05	0.000662	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AVP—germ cell cancer	2.54e-05	0.000647	CbGpPWpGaD
Temsirolimus—MTOR—Disease—KIT—germ cell cancer	2.53e-05	0.000645	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MYC—germ cell cancer	2.47e-05	0.000631	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CRABP1—germ cell cancer	2.27e-05	0.00058	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.22e-05	0.000565	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CRABP1—germ cell cancer	2.14e-05	0.000546	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—HRAS—germ cell cancer	2.03e-05	0.000518	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HRAS—germ cell cancer	1.95e-05	0.000498	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—HRAS—germ cell cancer	1.94e-05	0.000496	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FGFR3—germ cell cancer	1.93e-05	0.000492	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—KIT—germ cell cancer	1.77e-05	0.000452	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLC2A3—germ cell cancer	1.75e-05	0.000445	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MYC—germ cell cancer	1.73e-05	0.000442	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLC22A3—germ cell cancer	1.72e-05	0.000438	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TP53—germ cell cancer	1.42e-05	0.000363	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.4e-05	0.000357	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MYC—germ cell cancer	1.39e-05	0.000355	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HRAS—germ cell cancer	1.36e-05	0.000347	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HRAS—germ cell cancer	1.18e-05	0.000302	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HRAS—germ cell cancer	1.09e-05	0.000279	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MYC—germ cell cancer	9.75e-06	0.000248	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TP53—germ cell cancer	8e-06	0.000204	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HRAS—germ cell cancer	7.66e-06	0.000195	CbGpPWpGaD
